Effect of dapagliflozin alone and in combination with insulin in a rat model of type 1 diabetes

Dapagliflozin is a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor; it reduces glucose reabsorption via the kidney and increases the glucose excretion in urine. This inhibitor functions through a unique insulin-independent mechanism, and is therefore a potential new approach for the treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: SAYED, Noha, ABDALLA, Osama, KILANY, Omnia, DESSOUKI, Amina, YOSHIDA, Toshinori, SASAKI, Kazuaki, SHIMODA, Minoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Veterinary Science 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192721/
https://www.ncbi.nlm.nih.gov/pubmed/32161237
http://dx.doi.org/10.1292/jvms.19-0450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192721/
https://www.ncbi.nlm.nih.gov/pubmed/32161237
http://dx.doi.org/10.1292/jvms.19-0450

Ejemplares similares